 Notes from the East
Woods musings on opportunities in the life science
marketplace
December 2009
|
|
|
|
Greetings!
|
Firewood not only keeps us warm, but helps us penetrate competitive markets. Please have a read and feel free to let me know what you think. Thanks.
Regards,
Paul Danis Founder and Principal
ps. We have updated our website and included past Notes so you can peruse them here.
|
|
|
|
|
|
Splitting Logs and Competition
|
A small dent. That's
all that resulted from whacking the wood with a 6 pound maul as hard as I could. Being nearly winter, I'm urgently trying to
get all the wood split before the snows come.
Most logs yield to the force, splitting into neat chunks ready for
stacking. But take a curly-grained white
oak and I give up after 7 or 8 swings at the darn thing and throw it on
the pile whole. Similarly entering
markets with entrenched competitors usually gives the same result - you bounce
right off and don't get any penetration.
So what can you do about this situation? Often very appealing markets are right in
front of you, and it is obvious that the customers would be much better off
with your product. Why can't you just go
get a little bit of the market and grow from there? You're not trying to knock out the market
leader, just nibble a little away from the edge. Sounds logical....except it doesn't work, and similar failed logic is
applied time and again in markets with dominant players.
The main lesson is don't challenge the leader on their terms. Here are a few other approaches that should give better results.
- Try an end around.
Look for opportunity just beyond the edge of the market, perhaps in
adjacent segments. After getting
traction there, you can parlay that momentum towards the target with better
chances of success.
- Try to see some gaps in the current offerings. Maybe there is a portion of the customer's
workflow that is underserved. Focusing
efforts on satisfying this may give you the sales you need to eventually
challenge the leader.
- Like the resistant oak above, sometimes a bigger maul will
do the trick. There are 12 pounders that
would have probably split the log on the first swing. You can sometime use very large (aka
expensive) efforts to get your products accepted in the market. It's not the best approach, but if you
absolutely must attack the leader, you need to use the 12 pounder.
- Find someone to lend a hand. Partner with someone that is participating in
the market and form a mutually beneficial relationship. You will need to give up something to do this,
but you will get into the fight and you'll have some success.
- Finally, maybe there are some totally novel approaches that
you can create. I have seen "firewood
processors" where you load up whole 30 ft logs and out the end comes split
firewood. No need for mauls, chainsaws, and tired
backs - just hydraulics and petrol (and $$, of course).
So when the best opportunity for your products happens to be
the market governed by a potentate, put on your thinking cap and figure out
some clever ways to get there. Whatever
you do, don't charge in expecting to take a little bit away. Like the recalcitrant white oak, you will
bounce right off.
|
Life Science Market Update
|
|
Index
|
November Value
|
Change YTD
|
Yearly High
|
Yearly Low
|
|
EC BioTools
|
634
|
43%
|
639
|
411
|
|
EC BigPharma
|
782
|
9%
|
782
|
587
|
|
EC Biotech
|
537
|
6%
|
556
|
446
|
All indices recovered nicely from last month's dip, especially BigPharma that has risen to a new yearly high. Advances were nearly across the board for BigPharma while Biotech advances led declines 4 to 1 and BioTools 2 to 1. Star of the month goes to Human Genome Sciences up nearly 50% on positive news for its lupus med. Noteworthy is the disappearance of Schering and Wyeth from the BigPharma index as they now join their new families, Merck and Pfizer, resp. To maintain a balanced perspective on the markets, Lundbeck and King Pharmaceuticals are now part of the BigPharma index
EC BioIndex November 2009
---------------------
Many of the life science
indices currently available are a mixture of various types of companies. In
order to better assess the situation in the different segments, Eastwoods
Consulting has created these price-weighted indices for the sectors of large
pharmaceutical companies, biotech companies, and life science research tools
companies.
-
EC BioTools Index - A, ACCL, AFFX, BEC, BIO, BRKR,
CALP, DNEX, HBIO, HLCS, ILMN, LIFE, LMNX, PKI, QGEN, SIAL,
TMO, VARI, WAT
-
EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, LUN, ABT,
LLY, AZN, WYE, BMY, NVO, BAX, TEVA, KG, ROG.VX
-
EB Biotech Index - AMGN, GENZ, BIIB, CEPH, GILD,
BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, VRTX, THRX, HGSI, SGMO, NKTR
-
Prices are
taken at the close of each month. YTD is the year to date change taken from the end of December, 2008.
|
|
| About Eastwoods Consulting
|
Translating Innovations into Profits for the Life Science IndustrysmEastwoods Consulting helps life science companies grow their businesses. Please visit our web site or contact us to learn more about how we help companies succeed in competitive markets.
|
Copyright © 2009, Eastwoods Consulting. This
publication may be freely redistributed in full or in part as long as full
attribution including our contact information and web address, are included. Eastwoods is a registered servicemark of Eastwoods Consultng.
|
|
|
|
|